TUBERSOL

This brand name is authorized in United States. It is also authorized in Canada, Israel, New Zealand.

Active ingredients

The drug TUBERSOL contains one active pharmaceutical ingredient (API):

1	Tuberculin UNII I7L8FKN87J - TUBERCULIN PURIFIED PROTEIN DERIVATIVE
	Tuberculin PPD is indicated for the detection of a delayed hypersensitivity reaction to tuberculin as an aid in the detection of infection with Mycobacterium tuberculosis.
	Read more about Tuberculin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TUBERSOL Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V04CF01	Tuberculin	V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CF Tuberculosis diagnostics
Discover more medicines within V04CF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00317268
IL	מִשְׂרַד הַבְּרִיאוּת	6970
NZ	Medicines and Medical Devices Safety Authority	2238
US	FDA, National Drug Code	49281-752, 50090-0261